Harbor Capital Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
5,550
+11
+0.2% +$3.04K 0.08% 316
2026
Q1
$1.64M Sell
5,539
-1,587
-22% -$471K 0.13% 235
2025
Q4
$1.95M Sell
7,126
-10
-0.1% -$2.72K 0.15% 179
2025
Q3
$1.93M Buy
7,136
+191
+3% +$52K 0.15% 180
2025
Q2
$1.91M Sell
6,945
-41
-0.6% -$11.2K 0.08% 311
2025
Q1
$1.85M Sell
6,986
-1,027
-13% -$253K 0.08% 299
2024
Q4
$1.86M Buy
8,013
+203
+3% +$46.7K 0.08% 311
2024
Q3
$1.72M Buy
7,810
+45
+0.6% +$9.31K 0.07% 343
2024
Q2
$1.53M Buy
7,765
+44
+0.6% +$9.09K 0.12% 254
2024
Q1
$1.66M Buy
+7,721
New +$1.62M 0.22% 109

Other funds holding CME

Harbor Capital Advisors's CME Position: Q2 2026 in Review

Harbor Capital Advisors increased its CME Group (CME) stake by 0.2% in Q2 2026, buying an estimated $3.04K and bringing the position to 5,550 shares worth $1.23M. The position accounts for 0.08% of the portfolio, ranked #316.

Harbor Capital Advisors first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.95M in Q4 2025. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Harbor Capital Advisors held 5,550 shares of CME Group worth $1.23M as of Q2 2026.
  • Harbor Capital Advisors bought 11 CME Group shares in Q2 2026, an estimated $3.04K.
  • CME Group made up 0.08% of Harbor Capital Advisors's portfolio in Q2 2026, its #316 holding.
  • Harbor Capital Advisors first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • Harbor Capital Advisors's CME Group position peaked at $1.95M in Q4 2025.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.